Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, decreases the expression of Interleukin-2 via down regulation of its target gene, 16/April/2014, 6.45 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, decreases the expression of Interleukin-2 via down regulation of its target gene, 16/April/2014, 6.45 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK via down regulation of its target gene, 16/April/2014, 6.40 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK via down regulation of its target gene, 16/April/2014, 6.41 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Big-h3 via down regualtion of its target gene, 16/April/2014, 6.38 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Big-h3 via down regualtion of its target gene, 16/April/2014, 6.39 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Sprouty Homolog-1 via down regualtion of its target gene, 16/April/2014, 6.37 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Sprouty Homolog-1 via down regualtion of its target gene, 16/April/2014, 6.37 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Natural product-based cancer therapeutics: Hesperitin, a flavonoid enriched in citrus fruits, increases the expression of tumor suppressor Big-h3 via down regulation of its target gene, 15/April/2014, 21.50
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Natural product-based cancer therapeutics: Hesperitin, a flavonoid enriched in citrus fruits, increases the expression of tumor suppressor Big-h3 via down regulation of its target gene, 15/April/2014, 21.50, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Natural product-based cancer therapeutics: Hesperitin, a flavonoid enriched in citrus fruits, increases the expression of tumor suppressor p53 homologue TAp63 via down regulation of its target gene, 15/April/2014, 21.48
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Natural product-based cancer therapeutics: Hesperitin, a flavonoid enriched in citrus fruits, increases the expression of tumor suppressor p53 homologue TAp63 via down regulation of its target gene, 15/April/2014, 21.48, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org